Affiliation:
1. Selçuk Üniversitesi Tıp Fakültesi
2. SELÇUK ÜNİVERSİTESİ, TIP FAKÜLTESİ
3. beyhekim devlet hastanesi
4. sağlık bilimleri üniversitesi, konya şehir hastanesi
5. UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER
6. necip fazıl city hospital
Abstract
Purpose: The objectives of the present study were to develop biochemical indices as a more practical way for the early diagnosis of cases with suspected metabolic dysfunction-assosiated steatotic liver disease (MASLD) and to develop easy biomarkers to enable clinicians to recognize MASLD in obese children.
Materials and Methods: A total of 90 patients who had MASLD and 70 healthy volunteering children between the ages of 6-18 who were diagnosed with reference to the ESPGHAN 2012 Guideline between January 2020 and March 2023 were included. Age, gender, Anthropometric measurements and biochemical analysis were determined. Some Biochemical ratios such as HOMA-IR, HOMA-β, FGIR, QUICKI, AIP etc were calculated.
Results: There were 40 (44.4%) girls and 50 (55.6%) boys in the patient group.A positive correlation was found between AST, GGT, TSH, LDL, TG, total cholesterol, HDL, FAS, insulin, HOMA-IR, HOMA-β, QUICKI score, FGIR, MHR, LHR, LKR, THR ALT/AST ratios and Systemic Immun Inflammatory Index values in the analysis. The ROC analysis results of the HOMA-IR value was taken as 2.94, the specificity of the diagnostic value was found to be 52.20% and the sensitivity was 80.0%.
Conclusion: MASLD has an increasing trend today.Based on the design of the present study, it was concluded that almost all of the biochemical parameters and biomarkers obtained are among the most accurate and useful indices to determine MASLD and IR and predict complications.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference52 articles.
1. Margolis-Gil M, Yackobovitz-Gavan M, Phillip M, Shalitin S. Which predictors differentiate between obese children and adolescents with cardiometabolic complications and those with metabolically healthy obesity? Pediatr Diabetes. 2018;19:1147-55.
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. Lancet. 2017:16;390:2627-42.
3. T.C. Sağlık Bakanlığı. Türkiye Beslenme Ve Sağlık Araştırması 2010: Beslenme Durumu Ve Alışkanlıklarının Değerlendirilmesi Sonuç Raporu. Ankara, T.C Sağlık Bakanlığı, 2014.
4. World Health Organization Childhood Overweight And Obesity. Geneva, World Health Organization, 2016.
5. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:99-112.